Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia (Q40101776)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia |
scientific article |
Statements
1 reference
Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia (English)
1 reference
Dijoseph JF
1 reference
Dougher MM
1 reference
Armellino DC
1 reference
Evans DY
1 reference
Damle NK
1 reference
26 July 2007
1 reference
1 reference
21
1 reference
11
1 reference
2240-2245
1 reference
Identifiers
1 reference
1 reference